<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE86899" accession="SRP089825">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP089825</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA342860</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE86899</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Enhanced Pluripotent Cell Function through miR-203-mediated Control of DNA Methylation</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>Maintaining a full differentiation potential along self-renewal ability is a major property of stem cells during development and regeneration. miR-203 is a microRNA previously involved in skin differentiation and tumor suppression. We show here that transient expression of miR-203 enhances the potential of embryonic (ESC) and induced pluripotent stem cells (iPSC) in contributing to multiple lineages without decreasing their self-renewal properties. In fact, miR-203 significantly improves the efficiency of ES/iPS cells in the generation of quimeras and tetraploid complementation assays, in addition to improving the generation of complex teratomas and embryo-like structures in vivo. These effects are mediated by the direct miR-203-dependent repression of de novo DNA methyltransferases Dnmt3a and Dnmt3b, leading to genome-wide demethylation of pluripotent cells. Transient exposure to miR-203 improves functional differentiation and maturation of pluripotent cells into cardiomyocytes in a Dnmt3a/b-dependent manner, suggesting the possible therapeutic uses of this microRNA in regenerative medicine. Overall design: The general idea was to analyze the transcriptomic profile of miR-203 transiently over-expressing IPSCs, and compare different time points, from t=0 (before DOX treatment) to embryoid bodies formation. miR-203 tKI IPSCs were transiently induced by doxycycline treatment for 5 days, and then the following time points were analyzed: t=10 (5 days after DOX treatment); t=25 (20 days after DOX treatment) and t=32 (7 days after embryoid body differentiation).</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE86899</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
    <STUDY_LINKS>
      <STUDY_LINK>
        <XREF_LINK>
          <DB>pubmed</DB>
          <ID>32614092</ID>
        </XREF_LINK>
      </STUDY_LINK>
    </STUDY_LINKS>
    <STUDY_ATTRIBUTES>
      <STUDY_ATTRIBUTE>
        <TAG>parent_bioproject</TAG>
        <VALUE>PRJNA322009</VALUE>
      </STUDY_ATTRIBUTE>
    </STUDY_ATTRIBUTES>
  </STUDY>
</STUDY_SET>
